| 000 | 01692 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513232139.0 | ||
| 264 | 0 | _c20010329 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0167-594X | ||
| 024 | 7 |
_a10.1023/a:1006454427026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRajkumar, S V | |
| 245 | 0 | 0 |
_aA randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cSep 2000 |
||
| 300 |
_a255-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aReid, J M | |
| 700 | 1 | _aNovotny, P J | |
| 700 | 1 | _aSafgren, S L | |
| 700 | 1 | _aScheithauer, B W | |
| 700 | 1 | _aJohnson, P S | |
| 700 | 1 | _aNair, S | |
| 700 | 1 | _aMorton, R F | |
| 700 | 1 | _aHatfield, A K | |
| 700 | 1 | _aKrook, J E | |
| 700 | 1 | _aAmes, M M | |
| 700 | 1 | _aBuckner, J C | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 49 _gno. 3 _gp. 255-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1006454427026 _zAvailable from publisher's website |
| 999 |
_c11150801 _d11150801 |
||